Follow the JW홀딩스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, JW홀딩스 has published 49 public disclosures. Market capitalisation: €266.4bn. The latest transaction was reported on 3 July 2026 (Other). Among the most active insiders: 이경하. Every trade is openly available.
49
Insider Decl.
0
Thresholds
·
30 ops.
Buy Volume
·
0 ops.
Sell Volume
4Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 742 of 26,211 companies
82.4
score / 100
Value
97
Quality
67
FCF yld41%
Earn yld22%
EV/EBITDA3.0x
ROE22%
Gross mgn51%
Net mgn6.0%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
JW홀딩스 is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and commercialization of pharmaceutical products.